Pregnant women of advanced age faced with adverse changes in the number of insulin receptors and the insulin receptor signaling pathway, leading to insulin resistance and pancreatic β-cell defects, which increased the risk of GDM (33). The gene discussed is INS; the disease is gestational diabetes.